CWWeekly February 11th 2008 Issue

Friday, February 15, 2008 12:32 PM

Top News

 

Veritas Medicine Restructures Business and Drops Trial Listing Service

Cambridge, Mass.-based Veritas Medicine, a clinical trial services company, has discontinued its patient recruitment services and laid off a number of employees. According to Veritas, it is restructuring the company to focus solely on its clinical trial disclosure business. The company’s clinical trial listing service and patient screening business will be terminated. Veritas stated it ceased providing patient recruitment services on Feb. 8.

PPD Buys Russian CRO InnoPharm

Wilmington, N.C.-based PPD acquired contract research organization (CRO) InnoPharm, based in Smolensk, Russia. InnoPharm has a staff of 300 and has additional offices in Moscow, St. Petersburg and Kiev, Ukraine. It offers late-stage services in clinical monitoring, data management and biostatistics. No financial details of the transaction were given.

Other breaking news...      

  • Covance reports jump in fourth quarter revenue...
  • Medidata wins a contract with Eliassen Group...

Company Profile: An interview with William Cooney, president and chief executive officer, MedPoint Communications

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs